Globus Medical Reports Second Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Northland Capital Markets Upgrades Globus Medical (GMED) to Outperform
August 6, 2020 7:48 AM EDTNorthland Capital Markets analyst Jason Wittes upgraded Globus Medical (NYSE: GMED) from Market Perform to Outperform with a price target of $65.00.
The analyst commented, "2Q revs of $148.9mm (-23.4%) and EPS of $0.07, easily bested consensus of $99.7mm and ($0.11). Not a complete surprise,... More
Globus Medical (GMED) Tops Q2 EPS by 18c
August 5, 2020 5:13 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.07, $0.18 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $148.9 million versus the consensus estimate of $99.73 million.
The Globus Team performed extremely well in the second quarter, said Dave Demski, President and CEO. Our worldwide revenue was down 23% in the quarter, an exceptional result when compared to our... More
